Abstract

Male infertility is an important health concern that is expected to have a major genetic etiology. Although high-throughput sequencing has linked gene defects to more than 50% of rare and severe sperm anomalies, less than 20% of common and moderate forms are explained. We hypothesized that this low success rate could at least be partly due to oligogenic defects - the accumulation of several rare heterozygous variants in distinct, but functionally connected, genes. Here, we compared fertility and sperm parameters in male mice harboring one to four heterozygous truncating mutations of genes linked to multiple morphological anomalies of the flagellum (MMAF) syndrome. Results indicated progressively deteriorating sperm morphology and motility with increasing numbers of heterozygous mutations. This first evidence of oligogenic inheritance in failed spermatogenesis strongly suggests that oligogenic heterozygosity could explain a significant proportion of asthenoteratozoospermia cases. The findings presented pave the way to further studies in mice and man.

Data availability

Figure 5 - Source Data 1, Figure 6 - Source Data 1 and Figure 7 - Source Data 1 contain the numerical data used to generate the figures.

Article and author information

Author details

  1. Guillaume Martinez

    CHU Grenoble-Alpes, Grenoble, France
    For correspondence
    gmartinez@chu-grenoble.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7572-9096
  2. Charles Coutton

    CHU Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Corinne Loeuillet

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Caroline Cazin

    CHU Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Jana Muroňová

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Magalie Boguenet

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Emeline Lambert

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Magali Dhellemmes

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Geneviève Chevalier

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Jean-Pascal Hograindleur

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Charline Vilpreux

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Yasmine Neirijnck

    Department of Genetic Medicine and Development, University of Geneva Medical School, Genève, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  13. Zine Eddine Kherraf

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Jessica Escoffier

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8166-5845
  15. Serge Nef

    Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  16. Pierre F Ray

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  17. Christophe Arnoult

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    For correspondence
    christophe.arnoult@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3753-5901

Funding

Agence Nationale de la Recherche (ANR-19-CE17-0014)

  • Pierre F Ray
  • Christophe Arnoult

Agence Nationale de la Recherche (ANR-21-CE17-0007)

  • Guillaume Martinez
  • Charles Coutton

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were conducted according to a protocol approved by the local Ethics Committee (ComEth Grenoble No. 318), by the French government (ministry agreement number #7128 UHTA-U1209-CA), and by the Direction Générale de la Santé (DGS) for the State of Geneva.

Copyright

© 2022, Martinez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 903
    views
  • 144
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Guillaume Martinez
  2. Charles Coutton
  3. Corinne Loeuillet
  4. Caroline Cazin
  5. Jana Muroňová
  6. Magalie Boguenet
  7. Emeline Lambert
  8. Magali Dhellemmes
  9. Geneviève Chevalier
  10. Jean-Pascal Hograindleur
  11. Charline Vilpreux
  12. Yasmine Neirijnck
  13. Zine Eddine Kherraf
  14. Jessica Escoffier
  15. Serge Nef
  16. Pierre F Ray
  17. Christophe Arnoult
(2022)
Oligogenic heterozygous inheritance of sperm abnormalities in mouse
eLife 11:e75373.
https://doi.org/10.7554/eLife.75373

Share this article

https://doi.org/10.7554/eLife.75373

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.

    1. Cell Biology
    2. Neuroscience
    Qi Jia, Drew Young ... Derek Sieburth
    Research Article

    The gut-brain axis mediates bidirectional signaling between the intestine and the nervous system and is critical for organism-wide homeostasis. Here, we report the identification of a peptidergic endocrine circuit in which bidirectional signaling between neurons and the intestine potentiates the activation of the antioxidant response in Caenorhabditis elegans in the intestine. We identify an FMRF-amide-like peptide, FLP-2, whose release from the intestine is necessary and sufficient to activate the intestinal oxidative stress response by promoting the release of the antioxidant FLP-1 neuropeptide from neurons. FLP-2 secretion from the intestine is positively regulated by endogenous hydrogen peroxide (H2O2) produced in the mitochondrial matrix by sod-3/superoxide dismutase, and is negatively regulated by prdx-2/peroxiredoxin, which depletes H2O2 in both the mitochondria and cytosol. H2O2 promotes FLP-2 secretion through the DAG and calcium-dependent protein kinase C family member pkc-2 and by the SNAP25 family member aex-4 in the intestine. Together, our data demonstrate a role for intestinal H2O2 in promoting inter-tissue antioxidant signaling through regulated neuropeptide-like protein exocytosis in a gut-brain axis to activate the oxidative stress response.